Skip to main content
. 2022 Apr 23;8:223. doi: 10.1038/s41420-022-00919-4

Fig. 4. CRCSC-exos upregulating miR-17-5p facilitates malignant behaviors of HCT116 cells.

Fig. 4

A miR-17-5p expression in CRC tissues and adjacent normal tissues detected using RT-qPCR (n = 70); B proliferation of HCT116 cells detected using colony-formation assay after treated with CRCSC-exos transmitting miR-17-5p mimic/inhibitor; C proliferation of HCT116 cells detected using CCK-8 assay after treated with CRCSC-exos transmitting miR-17-5p mimic/inhibitor; D apoptosis of HCT116 cells detected using flow cytometry after treated with CRCSC-exos transmitting miR-17-5p mimic/inhibitor; E migration and invasion of HCT116 cells detected using Transwell assay after treated with CRCSC-exos transmitting miR-17-5p mimic/inhibitor. The cell experiments were repeated three times; *P < 0.05 vs the miR-17-5p-NC-Exo group; the measurement data were expressed as mean ± standard deviation.